Literature DB >> 8101213

Purkinje cell survival is differentially regulated by metabotropic and ionotropic excitatory amino acid receptors.

H T Mount1, C F Dreyfus, I B Black.   

Abstract

We previously reported that trophic factors and neurotransmitters in concert regulate survival of cultured cerebellar Purkinje cells. In particular, excitatory amino acid (EAA) transmitters and NGF increased survival, whereas neither alone was effective. In the present studies, we sought to identify molecular mechanisms through which EAAs participate in the survival-promoting interaction. Initially, we characterized the potential role of ionotropic EAA receptors by exposing cultures to the antagonists MK-801, D-2-amino-5-phosphonovaleric acid, and 6,7-dinitroquinoxalinedione. Each increased cell number, suggesting that endogenous ionotropic activity decreased survival. To determine whether metabotropic EAA receptor stimulation modulates survival, the metabotropic agonist ACPD ([1S,3R]-1-aminocyclopentane-1,3-dicarboxylic acid; 1 microM) was tested. ACPD alone had no effect on survival. However, simultaneous exposure to ACPD and NGF significantly increased Purkinje number. Moreover, this increase in survival was blocked by L-AP3 [L(+)-2-amino-3-phosphonopropionic acid; 1 microM], a putative antagonist of certain metabotropic responses. L-AP3 also reduced cell number in the absence of exogenous EAA. Thus, endogenous metabotropic stimulation is normally necessary for survival. In sum, these studies reveal a novel mechanism whereby an excitatory neurotransmitter shapes neural development by simultaneous trophic and regressive actions that are, respectively, mediated by metabotropic and ionotropic EAA receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8101213      PMCID: PMC6576674     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  13 in total

1.  Heterogeneous conductance levels of native AMPA receptors.

Authors:  T C Smith; L Y Wang; J R Howe
Journal:  J Neurosci       Date:  2000-03-15       Impact factor: 6.167

Review 2.  Neurotrophic effects of AMPA.

Authors:  Cristina Limatola
Journal:  Cerebellum       Date:  2004       Impact factor: 3.847

3.  Granule neuron regulation of Purkinje cell development: striking a balance between neurotrophin and glutamate signaling.

Authors:  M E Morrison; C A Mason
Journal:  J Neurosci       Date:  1998-05-15       Impact factor: 6.167

4.  Functional NMDA receptors are transiently active and support the survival of Purkinje cells in culture.

Authors:  M Yuzaki; D Forrest; L M Verselis; S C Sun; T Curran; J A Connor
Journal:  J Neurosci       Date:  1996-08-01       Impact factor: 6.167

5.  L-serine and glycine serve as major astroglia-derived trophic factors for cerebellar Purkinje neurons.

Authors:  S Furuya; T Tabata; J Mitoma; K Yamada; M Yamasaki; A Makino; T Yamamoto; M Watanabe; M Kano; Y Hirabayashi
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

6.  Glutamate transporter protein subtypes are expressed differentially during rat CNS development.

Authors:  A Furuta; J D Rothstein; L J Martin
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

7.  The activation of metabotropic glutamate receptors protects nerve cells from oxidative stress.

Authors:  Y Sagara; D Schubert
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

8.  Differential modulation of carbachol and trans-ACPD-stimulated phosphoinositide turnover following traumatic brain injury.

Authors:  T M Delahunty; J Y Jiang; R T Black; B G Lyeth
Journal:  Neurochem Res       Date:  1995-04       Impact factor: 3.996

Review 9.  Glutamate antagonists are neurotoxins for the developing brain.

Authors:  Angela M Kaindl; Chrysanthy Ikonomidou
Journal:  Neurotox Res       Date:  2007-04       Impact factor: 3.911

10.  Glutamate as a hippocampal neuron survival factor: an inherited defect in the trisomy 16 mouse.

Authors:  L L Bambrick; P J Yarowsky; B K Krueger
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.